Review of graft-versus-host disease

V Ramachandran, SS Kolli, LC Strowd - Dermatologic Clinics, 2019 - derm.theclinics.com
Methods A PubMed search was conducted using the search terms “graft versus host
disease,”“acute GVHD,”“chronic GVHD,”“pathophysiology,”“diagnosis,” and “treatment.” …

[HTML][HTML] Extracellular matrix stiffness—The central cue for skin fibrosis

K Wang, D Wen, X Xu, R Zhao, F Jiang… - Frontiers in Molecular …, 2023 - frontiersin.org
Skin fibrosis is a physiopathological process featuring the excessive deposition of
extracellular matrix (ECM), which is the main architecture that provides structural support …

[HTML][HTML] LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma

C Gur, SY Wang, F Sheban, M Zada, B Li, F Kharouf… - Cell, 2022 - cell.com
Systemic sclerosis (scleroderma, SSc) is an incurable autoimmune disease with high
morbidity and mortality rates. Here, we conducted a population-scale single-cell genomic …

[HTML][HTML] EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

HM Schoemans, SJ Lee, JL Ferrara, D Wolff… - Bone marrow …, 2018 - nature.com
Several international recommendations address the assessment of graft-versus-host
disease (GvHD) after hematopoietic cell transplantation (HCT). This position statement by …

A review of ocular graft-versus-host disease: pathophysiology, clinical presentation and management

JT Carreno-Galeano, TH Dohlman, S Kim… - Ocular immunology …, 2021 - Taylor & Francis
Graft-versus-host disease is a common complication following allogeneic hematopoetic
stem cell transplantation that can affect multiple organ systems, including the eyes. Ocular …

[HTML][HTML] Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review

R Maglie, G Genovese, F Solimani, A Guglielmo… - American Journal of …, 2020 - Springer
Haematological malignancies induce important alterations of the immune system, which
account for the high frequency of autoimmune complications observed in patients …

[PDF][PDF] Chronic graft-versus-host disease

D Wolff, A Lawitschka - The EBMT handbook: hematopoietic stem …, 2019 - library.oapen.org
Chronic GVHD (cGVHD) is the most relevant cause of late non-relapse morbidity and
subsequent mortality (approximately 25%) following allo-HSCT (Grube et al. 2016). Its …

Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease

D García‐Bernal, M Palomo… - Journal of Cellular …, 2020 - Wiley Online Library
Allogeneic hematopoietic stem cell transplantation (allo‐HCT) is an effective therapy for the
treatment of high‐risk haematological malignant disorders and other life‐threatening …

Understanding and treatment of cutaneous graft-versus-host-disease

J Hong, J Fraebel, Y Yang, E Tkacyk, C Kitko… - Bone Marrow …, 2023 - nature.com
The skin is the outermost mechanical barrier where dynamic immune reactions take place
and is the most commonly affected site in both acute and chronic graft-versus-host disease …

Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer

N Bayer, B Hausmann, RV Pandey, F Deckert, LM Gail… - Leukemia, 2022 - nature.com
The composition of the gut microbiome influences the clinical course after allogeneic
hematopoietic stem cell transplantation (HSCT), but little is known about the relevance of …